#USA #Palo Alto #Segmed #Imaging #Verily

Segmed Partners with Verily to Expand Access to Real-World Imaging Data

In a significant move for the healthcare research community, Segmed, Inc., renowned for its expertise in real-world medical imaging and multimodal data, has officially partnered with Verily, a leader in precision health and AI. This collaboration promises to enhance accessibility to de-identified diagnostic-grade imaging, thereby accelerating research and development in the medical field.

The Importance of the Partnership

Segmed aims to provide its extensive library of imaging and corresponding clinical data through Verily's precision health platform. This integration allows researchers to access carefully curated datasets within a secure and user-friendly environment. Such access is crucial for facilitating meaningful insights into medical conditions, particularly in fields like oncology, where precision in diagnostics is paramount.

The partnership's first major dataset will focus on breast cancer, featuring long-term data from patients who underwent digital breast tomosynthesis (DBT) exams. This is a notable inclusion, considering that roughly 150 million de-identified imaging exams from various modalities—including CT, MRI, X-ray, and more—are part of Segmed’s global imaging platform.

Enhanced Research Capabilities

According to David Gascoigne, CEO of Segmed, advanced imaging data is vital for precision medicine, especially when synergized with clinical datasets. This partnership not only broadens the horizon for high-quality imaging data access but also supports researchers in expediting essential diagnostics and therapeutic advancements.

Bharat Rajagopal, Chief Revenue Officer at Verily, echoed this sentiment, stating that integrating Segmed's datasets into their platform is a decisive step towards promoting AI-powered precision health. The goal is to arm researchers with the diverse and comprehensive data necessary to foster groundbreaking insights into healthcare.

Commitment to Privacy and Accessibility

Importantly, this collaboration underscores a commitment to responsible research practices, ensuring that higher accessibility does not come at the expense of patient privacy. Segmed remains devoted to privacy-first research methodologies, which are crucial for maintaining public trust in data-driven healthcare innovations.

As this partnership unfolds, researchers across academia and the life sciences sphere can expect essential tools and data to enhance their scientific endeavors, ultimately paving the way for more effective treatments and diagnostic processes in precision health.

About Segmed

Segmed operates a unique platform that strives to streamline access to a variety of real-world data, including critical imaging and clinical records. Collaborating with healthcare partners worldwide, Segmed facilitates an exchange of robust datasets, which can significantly contribute to advancements in healthcare through research and innovation. To learn more about their initiatives, visit www.segmed.ai.

About Verily

Verily positions itself at the intersection of technology and healthcare, crafting advanced AI-enabled solutions that transform diverse health data into actionable insights. The company’s innovations aim to foster a transformative approach towards healthcare, emphasizing personalized treatment modalities that improve care quality at a comprehensive level. To delve deeper into Verily’s endeavors, check their website at verily.com.